A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.
Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S, Brown BW, Desch JK, Norbash AM, Conrad CK, Guggino WB, Flotte TR, Wine JJ, Carter BJ, Reynolds TC, Moss RB, Gardner P.
Wagner JA, et al. Among authors: guggino wb.
Hum Gene Ther. 2002 Jul 20;13(11):1349-59. doi: 10.1089/104303402760128577.
Hum Gene Ther. 2002.
PMID: 12162817
Clinical Trial.